MétaCan
Menu
Back to cohort
Record W4416376916 · doi:10.1093/neuonc/noaf237

A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma

2025· article· en· W4416376916 on OpenAlexafffund
Alexander Landry, Justin Z. Wang, Vikas Patil, Andrew Ajisebutu, Chloe Gui, Leeor Yefet, Yosef Ellenbogen, Jeff Liu, Yasin Mamatjan, Qingxia Wei, Olivia Singh, Sheila Mansouri, Felix Ehret, David Capper, Aaron A Cohen-Gadol, Ghazaleh Tabatabai, Marcos Tatagiba, Felix Behling, Jill S. Barnholtz‐Sloan, Andrew E. Sloan, Lola B. Chambless, Alireza Mansouri, Serge Makarenko, Stephen Yip, Derek S. Tsang, Andrew Gao, Kenneth Aldape, Farshad Nassiri, Thomas Santarius, Warren R. Selman, Marta Couce, Priscilla K. Brastianos, Helen A. Shih, Wenya Linda Bi, Raymond Y. Huang, Patrick Y. Wen, Tobias Walbert, Ian Lee, Michelle M. Felicella, Chaya Brodie, Tathiane M. Malta, Ana Valéria Castro, Houtan Noushmehr, James P. Snyder, Francesco DiMeco, Andrea Saladino, Bianca Pollo, Christian Schichor, Jörg‐Christian Tonn, Timothy J. Kaufmann, Daniel H. Lachance, Caterina Giannini, Evanthia Galanis, Aditya Raghunathan, C. Oliver Hanemann, Karolyn Au, Roland Goldbrunner, Norbert Galldiks, Marco Timmer, Nils Ole Schimdt, Christel Herold‐Mende, Felix Sahm, Christine Jungk, Gerhard Jungwirth, Andreas von Deimling, Michael D. Jenkinson, Christopher P. Millward, Abdurrahman I. Islim, Katharine J. Drummond, Andrew Morokoff, Mirjam Renovanz, Antonio Santacroce, Christian la Fougère, Jens Schittenhelm, David R. Raleigh, Arie Perry, Nicholas Butowski, Manfred Westphal, Katrin Lamszus, Franz Ricklefs, Christian Mawrin, Craig Horbinski, Ho‐Keung Ng, Matija Snuderl, Sylvia C. Kurz, Erik P. Sulman, Gabriel Zada, Aaron Cohen‐Gadol, Viktor Zherebitskiy, Luke Hnenny, Ian F. Dunn, Jennifer Moliterno, Michael McDermott, Michael A. Vogelbaum, Mohsen Javadpour, Daniel M. Fountain, Tiit Mathiesen, Kenneth Aldape, Omar Pathmanaban, Paul C. Boutros, Tzannis Alkividias, Konstantinos Fountas, Kyle M. Walsh, Susan Short, Bruno Carvalho, Sybren L. N. Maas, Eelke M. Bos, Alper Dincer, Peter Paßlack, Maximilian Deng, Minesh P. Mehta, Yazmín Odia, Richard G. Everson, James A. Balogun, Evan Calabrese, Philipp Karschnia, Nico Teske, Laura Fariselli, Tobias Greve, Christina Arvaniti, Carolina Benjamin, Michael E. Ivan, Christina Jackson, Daniele Scartoni, Dante Amelio, Joshua D. Palmer, Jana Ivanidze, Quinn T. Ostrom, Duong Trung Kien, Mark W. Youngblood, Miguel Millareschavez, Malak AlThgafi, Sam R. Emerson, Michael Weller, Emilie LeRhun, Rafael Martínez-Pérez, Robert Smee, Rajarshi Mukherjee, Andrés Cervio, Clinton Turner, William Muirhead, Vitowanu Julius, J. Chen, Brij Karmur, Maciej M. Mrugała, Bryan J. Neth

Bibliographic record

VenueNeuro-Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicMeningioma and schwannoma management
Canadian institutionsPrincess Margaret Cancer CentreUniversity of TorontoUniversity of British ColumbiaUniversity Health Network
FundersCanadian Institutes of Health ResearchBrain Tumour Charity
KeywordsMeningiomaDNAMEDLINEAdjuvantIdentification (biology)DNA sequencing

Abstract

fetched live from OpenAlex

BACKGROUND: DNA methylation profiling can be used to robustly predict postsurgical outcomes and response to radiotherapy (RT) for meningioma patients. To allow for seamless integration of these complementary models into clinical practice, a practical framework is needed. METHODS: We leveraged a cohort of nearly 2000 surgically-treated meningiomas with DNA methylation profiling and clinical outcomes data. Existing methylation-based prediction models were dichotomized to yield four risk groups: low and high recurrent risk, each with RT sensitive and resistant subgroups. Risk groups were correlated with progression-free survival in the context of existing biomarkers including extent of resection and WHO grade. RESULTS: We first demonstrated that all risk groups benefit from gross total resection. All "high-risk, RT sensitive" tumors (n = 306, 15.7%) also benefited from adjuvant RT: after GTR, median PFS increased from 4.68 (4.13-9.48) years to not reached (P = .003); after subtotal resection (STR), from 2.12 (1.59-3.02) to 4.09 (3.41-not reached) years (P = .004). "Low-risk, RT sensitive cases" (n = 1207, 61.8%) also benefited from RT after STR (median PFS 7.39 (6.66-12.8) vs. 16.53 (10.35-not reached) years, P = .03), suggesting that RT be considered in these patients. Neither "low-risk RT resistant" (n = 84, 4.3%) nor "high-risk RT resistant" (n = 356, 18.2%) cases benefited from RT, and the latter group was associated with universally poor outcomes. CONCLUSIONS: We identify methylation-defined risk groups of meningioma for which additional benefit is gained from adjuvant RT, leading to a clinical decision-making framework for straightforward integration of molecular models into clinical practice.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.015
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: Simulation or modeling
GenreCandidate signal: Methods · Consensus signal: Methods
Teacher disagreement score0.029
Threshold uncertainty score0.058

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.015
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0020.001
Science and technology studies0.0010.001
Scholarly communication0.0030.001
Open science0.0030.003
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.143
GPT teacher head0.435
Teacher spread0.291 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSimulation or modeling
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicMeningioma and schwannoma managementFrench-language works237,207